Therapeutic Plan:  
 
Device Selection.1
: Utilize wearable insulin delivery systems such as the Omnipod 5 Automated Insulin Delivery System or Medtronic's MiniMed systems.Intervention: Compare the wearable insulin
delivery system with standard care (e.g., continuous subcutaneous insulin infusion [CSII] or multiple daily injections [MDI]).These devices integrate continuous glucose monitoring (CGM) data to adjust insulin delivery automatically.2.Patient Eligibility
Include patients aged
years and older with Type 1 Diabetes (T1D), focusing on both adults and children to assess efficacy across different age groups.- Time in Range (TIR):
The percentage of time blood glucose levels are within the target range (70-180 mg/dL
 
?Hemoglobin A1c (HbA1c) Levels: 
To assess overall glycemic control
 
?Monitoring Parameters
Track key outcomes such as:
 
?3.4.5.